Condition: Chronic Pelvic Pain Syndrome (CPPS) · Radiation-Induced Disorder · Radiotherapy Side Effects · Sponsor: Bernardino Clavo, MD, PhD
Gynecological cancers, including those affecting the ovaries, uterus, and cervix, represent a significant health burden for women. While survival rates have improved, many women experience chronic pelvic pain secondary to cancer treatment, especially radiotherapy and chemotherapy. This treatment-induced pelvic pain can be of difficult management and significantly affects patients' quality of life. In our experience, ozone therapy has emerged as a promising complementary treatment for pain relief in patients with chronic diseases, including side effects of cancer treatment. However, the genetic and epigenetic mechanisms influencing its effectiveness have not yet been thoroughly studied. The aim of this prospective study is to analyze how ozone therapy modulates the expression of certain genes and its impact on epigenetic clocks, which could help predict pain response.
This description comes directly from the study's public registry record.
Bernardino Clavo, MD, PhD · 34928449278 · bernardinoclavo@gmail.com
Francisco Rodríguez-Esparragón, BSc, PhD · 34928449288 · afrodesp@gmail.com
Always discuss trial participation with your own doctor first.
| Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC) | Las Palmas, Las Palmas, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06816095